IMAX affiliate files to sell 135,046 shares

IMAX affiliate filed a Form 144 to sell 135,046 shares of Common Stock (as of 04/10/2026).

Rhea-AI Filing Summary

IMAX affiliate filed a Form 144 to sell 135,046 shares of Common Stock (as of 04/10/2026). The shares were acquired as compensation via stock options on 06/07/2016 and the planned method is described as cashless exercise / same-day sale. The filing lists three dispositions in the prior three months by Richard Gelfond: 121,220 shares on 03/10/2026 for $4,860,837.15, 12,037 shares on 04/02/2026 for $481,520.93, and 12,987 shares on 04/06/2026 for $522,883.89.

Insights

Equity Markets Analyst

Form 144 shows an affiliate sale filing for 135,046 shares with recent sales by Richard Gelfond.

The filing records that the shares were acquired as compensation via stock options on 06/07/2016 and that the distribution method is a cashless exercise / same-day sale. Recent dispositions totaled 146,244 shares across three trades in March–April 2026 with proceeds shown.

Cash‑flow treatment and remaining holdings are not detailed in the excerpt; subsequent filings or transaction reports will show execution details and any additional sales.

Key Figures

Shares subject to Form 144: 135,046 shares Disposition on 03/10/2026: 121,220 shares Disposition on 04/02/2026: 12,037 shares +1 more

4 metrics

Shares subject to Form 144 135,046 shares as of 04/10/2026

Disposition on 03/10/2026 121,220 shares proceeds listed as $4,860,837.15

Disposition on 04/02/2026 12,037 shares proceeds listed as $481,520.93

Disposition on 04/06/2026 12,987 shares proceeds listed as $522,883.89

Key Terms

Form 144, cashless exercise, same-day sale, acquired as compensation

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cashless exercise financial

"Compensation -- Cashless exercise / same-day sale"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

acquired as compensation other

"Acquired as compensation -- Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IMAX's Form 144 report?

It reported an affiliate filing to sell 135,046 shares of common stock as of 04/10/2026. The shares were acquired as compensation via stock options on 06/07/2016.

Who sold shares and how many were sold recently?

Richard Gelfond reported recent dispositions of 121,220, 12,037, and 12,987 shares on 03/10/2026, 04/02/2026, and 04/06/2026, respectively. Proceeds for each trade are shown in the filing.

What sale method is described in the filing?

The filing describes the securities as acquired by cashless exercise / same-day sale from stock options, indicating option exercise tied to immediate disposition in the same transaction.

How much proceeds did the recent trades generate?

The filing lists proceeds of $4,860,837.15, $481,520.93, and $522,883.89 for the three reported trades on the respective dates in March and April 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/10/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corporation
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga Unknown L5K 1B1
Phone	1-905-403-6457
Name of Person for Whose Account the Securities are To Be Sold	Richard Gelfond
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	135046	5110140.64	53993017	04/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2016	Acquired as compensation -- Stock Options	Issue			135046	06/07/2016	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	03/10/2026	121220	4860837.15
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/02/2026	12037	481520.93
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/06/2026	12987	522883.89

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 12/9/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	04/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Richard Gelfond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)